People diagnosed with recurrent IDH-mutant grade 3 astrocytoma, a rare and aggressive brain cancer, lived roughly 11 months ...

New long‑term results from the RUBY clinical trial show that adding immunotherapy (dostarlimab) to chemotherapy may help some ...

An experimental vaccine that could offer one-stop prevention for both COVID-19 and influenza is showing positive results among older adults in trials, maker Moderna announced Monday. The shot—for now ...

Findings from a first-of-its-kind virtual trial in pulmonary medicine, conducted at Rutgers and many other institutions, suggest adding an inhaled corticosteroid to rescue therapy could sharply reduce ...

A treatment combination of avutometinib and defactinib is being evaluated in a new phase 3 trial for patients with low-grade serous ovarian cancer. A phase 3 trial analyzing the treatment combination ...

Moderna Inc. said its combination flu and COVID shot met the goals of a pivotal late-stage trial, bringing the company one step closer to a more convenient jab that could help combat vaccine fatigue.

Hello. It's Mark Kris, from Memorial Sloan Kettering. I'm about to say some things that will not make everyone happy. I would like to comment on a recently published article in The New England Journal ...

At an interim analysis, the regimen failed to improve progression-free survival and likely wouldn't yield overall survival benefits, the companies said.

Editor's note: Please check back on Oct. 22 when the full data of EV-302 are presented at ESMO 2023. Four weeks ago, Seagen and Astellas made waves when they revealed that the pairing of Padcev with ...